azomycin has been researched along with Experimental Hepatoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Curd, J; Duan, JX; Li, J; Li, S; Matteucci, M; Zhang, J | 1 |
| Brader, P; Fong, Y; Hricak, H; Humm, JL; Ling, CC; Reid, V; Riedl, CC; Wen, B; Woo, Y; Zanzonico, P | 1 |
| Alavi, A; Dolbier, WR; Evans, SM; Hustinx, R; Jenkins, WT; Kachur, AV; Karp, JS; Koch, CJ; Lord, EM; Shiue, CY; Shive, GG | 1 |
3 other study(ies) available for azomycin and Experimental Hepatoma
| Article | Year |
|---|---|
Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Enzyme Assays; Glutathione Reductase; Injections, Intraperitoneal; Liver Neoplasms, Experimental; Male; Mice; Molecular Structure; Nitroimidazoles; Phosphoramide Mustards; Thioredoxin-Disulfide Reductase; Time Factors; Treatment Outcome; Tumor Burden | 2010 |
Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort.
Topics: Animals; Disease Models, Animal; Half-Life; Hypoxia; Liver Neoplasms, Experimental; Misonidazole; Monosaccharides; Nitroimidazoles; Peritoneal Neoplasms; Positron-Emission Tomography; Rats; Tissue Distribution | 2008 |
Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1.
Topics: Animals; Cell Hypoxia; Fluorine Radioisotopes; Glioma; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nitroimidazoles; Rats; Rats, Inbred BUF; Rats, Inbred F344; Tomography, Emission-Computed | 2000 |